Results: Short-term (12-week) use for kickstarting weight loss
N Engl J Med 389:22212232 Kosiborod MN, Abildstrm SZ, Borlaug BA et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity
The reconstitution process (abbreviated) Swab both vial tops with alcohol Draw calculated water volume into syringe Inject water slowly down vial wall (not onto powder) Wait 30 seconds, then swirl gently (no shaking) Inspect for clarity (clear = good, cloudy = problem) Label vial with concentration and date Refrigerate at 2-8 degrees Celsius Use within 28 days Critical reminders Use bacteriostatic water, never sterile water for multi-dose vials
For antihistamines, the general principle endorsed by bariatric pharmacists and supported by BOMSS and SPS guidance is to favour immediate-release, crushable, or liquid preparations wherever possible, particularly in the early post-operative period
Recent Developments: Tirzepatide and Shortage Status On October 2, 2024, tirzepatide, a groundbreaking medication for diabetes and obesity, was removed from the FDAs drug shortage list
Q4: Is GHK-Cu better topical or injectable